38 Chapter 2 15. H. Rahman, O.M. Demir, F. Khan, M. Ryan, H. Ellis, M.T. Mills, et al., Physiological stratification of patients with angina due to coronary microvascular dysfunction, J. Am. Coll. Cardiol. 75 (20) (2020) 2538–2549. 16. V. Kunadian, A. Chieffo, P.G. Camici, C. Berry, J. Escaned, A. Maas, et al., An EAPCI expert consensus document on ischaemia with non-obstructive coronary arteries in collaboration with European society of Cardiology working group on coronary pathophysiology & microcirculation endorsed by coronary vasomotor disorders international study group, Eur. Heart J. 41 (37) (2020) 3504–3520. 17. L.J. Shaw, C.N. Bairey Merz, C.J. Pepine, S.E. Reis, V. Bittner, S.F. Kelsey, et al., Insights from the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies, J. Am. Coll. Cardiol. 47 (3) (2006) S4–s20. 18. M.R. Bell, P.B. Berger, D.R. Holmes Jr., C.J. Mullany, K.R. Bailey, B.J. Gersh, Referral for coronary artery revascularization procedures after diagnostic coronary angiography: evidence for gender bias? J. Am. Coll. Cardiol. 25 (7) (1995) 1650–1655. 19. J.S. Hochman, J.E. Tamis, T.D. Thompson, W.D. Weaver, H.D. White, F. Van de Werf, et al., Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global use of strategies to open occluded coronary arteries in acute coronary syndromes IIb investigators, N. Engl. J. Med. 341 (4) (1999) 226–232. 20. N. Mileva, S. Nagumo, T. Mizukami, J. Sonck, C. Berry, E. Gallinoro, et al., Prevalence of coronary microvascular disease and coronary vasospasm in patients with nonobstructive coronary artery disease: systematic review and meta-analysis, J. Am. Heart Assoc. 11 (7) (2022), e023207. 21. C.K.M. Boerhout, G.A. de Waard, J.M. Lee, H. Mejia-Renteria, S.H. Lee, J.H. Jung, et al., Prognostic value of structural and functional coronary microvascular dysfunction in patients with nonobstructive coronary artery disease; from the multicentre international ILIAS registry, EuroIntervention 18 (9) (2022) 719–728. 22. M.J. Bom, P.A. van Diemen, R.S. Driessen, H. Everaars, S.P. Schumacher, J. T. Wijmenga, et al., Prognostic value of [15O] H2O positron emission tomographyderived global and regional myocardial perfusion, Eur Heart J Cardiovasc Imaging 21 (7) (2020) 777–786. 23. V.R. Taqueti, M.F. Di Carli, Coronary microvascular disease pathogenic mechanisms and therapeutic options: JACC state-of-the-art review, J. Am. Coll. Cardiol. 72 (21) (2018) 2625–2641. 24. N.G. Kounis, G.M. Zavras, Histamineinduced coronary artery spasm: the concept of allergic angina, Br. J. Clin. Pract. 45 (2) (1991) 121–128. 25. M.B. Forman, J.A. Oates, D. Robertson, R.M. Robertson, L.J. Roberts 2nd, R. Virmani, Increased adventitial mast cells in a patient with coronary spasm, N. Engl. J. Med. 313 (18) (1985) 1138–1141. 26. A. Aziz, H.S. Hansen, U. Sechtem, E. Prescott, P. Ong, Sex-related differences invasomotor function in patients with angina and unobstructed coronary arteries, J. Am. Coll. Cardiol. 70 (19) (2017) 2349– 2358. 27. T. Frieling, Non-cardiac chest pain, Visc. Med. 34 (2) (2018) 92–96. 28. C. Bradley, C. Berry, Definition and epidemiology of coronary microvasculardisease, J. Nucl. Cardiol. 29 (4) (2022) 1763–1775. 29. MA Kelshiker, H Seligman, JP Howard, H Rahman, M Foley, AN Nowbar, et al.,Coronary flow reserve and cardiovascular outcomes: a systematic review and metaanalysis, Eur. Heart J. 43 (16) (2022), 1582–93.
RkJQdWJsaXNoZXIy MTk4NDMw